003120 — Ilsung IS Co Share Price
Last trade - 00:00- KR₩108bn
- -KR₩114bn
- KR₩69bn
- 31
- 64
- 19
- 29
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.28 | ||
| Price to Tang. Book | 0.28 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.56 | ||
| EV to EBITDA | -765.63 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.84% | ||
| Return on Equity | 3.41% | ||
| Operating Margin | -4.7% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 40,600.73 | 42,089.84 | 61,247.85 | 78,053.23 | 69,018.34 | n/a | n/a | 7.35% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -56.96 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ilsung IS Co Ltd, formerly Ilsung Pharmaceutical Co Ltd, is a Korea-based company mainly engaged in the pharmaceuticals manufacture and sale business. The Company’s products consist of penicillin antibiotics, contrast mediums, digestive drugs, cardiovascular agents, antihistamines, anti-diabetics, bone disease drugs, analgesics, muscle relaxants, anesthetics, skin disease drugs, cardiovascular drugs, psychiatry drugs, antivirals, antipyretics and others. The Company distributes its products through wholesalers, hospitals, pharmacies and others. The Company also provides consignment production services.
Directors
- Byeong Gang Yoon CHM (83)
- Jong Wuk Yoon CCE
- Seok Geun Yoon CCE (62)
- Hyeon Sik Kim MDR (51)
- Deok Geun Yoon OTH (53)
- Seong Yeol Lee OTH (52)
- Yeong Gu Cho OTH (48)
- Jung Gap Geum NID (70)
- Mun Su Kim NID (68)
- Seong Yun Kim NID (63)
- Seong Ho Lee NID (66)
- Yong Seok Son NID (54)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 15th, 1961
- Public Since
- January 14th, 1985
- No. of Shareholders
- 4,275
- No. of Employees
- 202
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KSE
- Shares in Issue
- 6,815,673
- Address
- 9, Wonhyo-ro 84-gil, Yongsan-gu, SEOUL, 04315
- Web
- https://www.ilsungis.com/
- Phone
- +82 232718800
- Auditors
- Woori Accountants
Upcoming Events for 003120
Similar to 003120
Aprogen Biologics
Korea Exchange - KSE
Boryung
Korea Exchange - KSE
Bukwang Pharm Co
Korea Exchange - KSE
Chong Kun Dang Pharmaceutical
Korea Exchange - KSE
CKD Bio
Korea Exchange - KSE
FAQ
As of Today at 21:15 UTC, shares in Ilsung IS Co are trading at KR₩15,820. This share price information is delayed by 15 minutes.
Shares in Ilsung IS Co last closed at KR₩15,820 and the price had moved by -20.02% over the past 365 days. In terms of relative price strength the Ilsung IS Co share price has underperformed the FTSE Developed Asia Pacific Index by -18.23% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Ilsung IS Co dividend yield is 6.32% based on the trailing twelve month period.
Last year, Ilsung IS Co paid a total dividend of KR₩1,000, and it currently has a trailing dividend yield of 6.32%. We do not have any data on when Ilsung IS Co is to next pay dividends.
We do not have data on when Ilsung IS Co is to next pay dividends. The historic dividend yield on Ilsung IS Co shares is currently 6.32%.
To buy shares in Ilsung IS Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩15,820, shares in Ilsung IS Co had a market capitalisation of KR₩108bn.
Here are the trading details for Ilsung IS Co:
- Country of listing: Korea, Republic of
- Exchange: KSC
- Ticker Symbol: 003120
Based on an overall assessment of its quality, value and momentum Ilsung IS Co is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Ilsung IS Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +4.03%.
As of the last closing price of KR₩15,820, shares in Ilsung IS Co were trading -2.26% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Ilsung IS Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩15,820.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Ilsung IS Co's management team is headed by:
- Byeong Gang Yoon - CHM
- Jong Wuk Yoon - CCE
- Seok Geun Yoon - CCE
- Hyeon Sik Kim - MDR
- Deok Geun Yoon - OTH
- Seong Yeol Lee - OTH
- Yeong Gu Cho - OTH
- Jung Gap Geum - NID
- Mun Su Kim - NID
- Seong Yun Kim - NID
- Seong Ho Lee - NID
- Yong Seok Son - NID